G, B., F, R., F, V., J, S., E, C., & B, V. (2025). Clinical value at baseline and follow-up of myeloperoxidase-antibodies in ANCA-associated vasculitis. Frontiers in immunology, 16, 1649708. https://doi.org/10.3389/fimmu.2025.1649708
Chicago Style (17th ed.) CitationG, Bossan, Roufosse F, Vandergheynst F, Smet J, Cogan E, and Vokaer B. "Clinical Value at Baseline and Follow-up of Myeloperoxidase-antibodies in ANCA-associated Vasculitis." Frontiers in Immunology 16 (2025): 1649708. https://doi.org/10.3389/fimmu.2025.1649708.
MLA (9th ed.) CitationG, Bossan, et al. "Clinical Value at Baseline and Follow-up of Myeloperoxidase-antibodies in ANCA-associated Vasculitis." Frontiers in Immunology, vol. 16, 2025, p. 1649708, https://doi.org/10.3389/fimmu.2025.1649708.